EUROPEAN RESPIRATORY & PULMONARY DISEASES – VOLUME 1 – SUMMER 2015
We are very pleased to present the first edition of European Respiratory and Pulmonary Diseases. Editorial Board member Marc Miravitlles gives an excellent introduction to the edition and highlights the key articles. We also welcome a letter from fellow Editorial Board member David Price, who gives an overview of this new journal.
European Respiratory and Pulmonary Diseases aims to keep busy physicians up to date on new data and salient developments within the respiratory field. The journal will publish unbiased, balanced reviews, editorials, case reports, satellite symposia and original research on topics of interest to the respiratory community. We also offer authors the opportunity to publish multimedia content of their work including podcasts, videos and slides.
We hope you find this edition useful and that it provides helpful information and discussions that are relevant to your practice and interests. Please peruse and enjoy the expert content and we welcome any feedback you may have.
touchRESPIRATORY is accepting submissions; please use the online submission system to submit your manuscript. For all enquiries about the journal, please contact:firstname.lastname@example.org
Foreword – European Respiratory & Pulmonary Diseases, 2015;1(1):11
Welcome to the first edition of European Respiratory and Pulmonary Diseases. This new annual journal aims to provide members of the respiratory community a wide range of high-quality review articles, editorials and case studies written by key opinion leaders from a variety of respiratory disciplines. This issue begins with an editorial from Almeida discussing new […]
Letter from the Editor
Letter from the Editor
Dear Colleagues It is an honor to welcome you to US Respiratory & Pulmonary Diseases. This new journal is an open access, bi-annual publication that aims to publish unbiased, balanced reviews, original research, case reports, symposium reports, and topical editorials on subjects of interest to the respiratory community. Areas of focus include, but are not […]
Wheezing Phenotypes in Childhood – Is it Already Asthma?
Wheezing in early childhood is among the most frequent respiratory symptoms. Despite its common occurrence, many children with early wheeze become symptom-free in later childhood and adolescence. However, early onset of recurrent wheeze is also associated with persistent asthma into adulthood, as well as to more severe, persistent lung function impairment.1–4 This illustrates the heterogeneity […]
Off-label Use of Drugs in Childhood Asthma
Asthma is among the most common respiratory illnesses in childhood and frequently requires the use of long-term control medication. Even though less than half of the children represent true therapyresistant asthma, they may require off-label use for adequate symptom control. Many drugs used in the treatment of allergic diseases are not appropriately studied in the […]
Asthma Exacerbations – The Focus For Treatment Of Severe Asthma?
Asthma is recognised by symptoms of cough, wheeze and breathlessness, which are characteristically variable and can be measured by reversible airflow obstruction. These affect the lives of asthmatics in numerous ways, including disturbed sleep, limitation of activity, the psychosocial impact of chronic disease and side effects (real and feared) of treatment.1 Asthma attacks (periodic worsening […]
Airway and Lung Infection
Tuberculosis Multidrug-resistant Tuberculosis – From Epidemiology to Treatment Design
Epidemiology Strains of Mycobacterium tuberculosis (M. tbc) are able, like other bacteria, to develop resistance against antibiotics. The first observations were published shortly after the introduction of streptomycin and were the basis of the current recommendation of combining several antibiotics for the treatment of tuberculosis (TB).1 Rigorous application of this principle could have possibly prevented […]
Sublingual Immunotherapy for Respiratory Allergy
In the late 1980s, sublingual allergen immunotherapy (SLIT) was proposed as an ‘alternative’ to subcutaneous allergen immunotherapy (SCIT).1,2 The main aim was to reduce systemic reactions and the risk of anaphylaxis, which were frequently associated with SCIT and also to increase the number of patients receiving allergen immunotherapy by facilitating its regular use at home. […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!